G5S-22268-34777
4 vaccinations
8 coded responses
33 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 688 / NE
- Registered
- 2020-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-15
Registered in v-safe
-
2020-12-15
Dose 1 — Pfizer-BioNTech
- 2020-12-15
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
-
2020-12-29
Survey response — day 14, dose 1MedDRA: Decreased appetite, Fatigue, Nausea — Feeling: GoodFree text: Slight nausea and anorexia on 12/26/20 and some continuing anorexia since then. Maybe a bit more fatigue than normal, but may have been due to Christmas holiday activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Dose 2 — Pfizer-BioNTech
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
-
2021-01-19
Survey response — day 14, dose 2MedDRA: Culture negative, Dizziness, Fatigue, Nausea, Office visit, SARS-CoV-2 test, SARS-CoV-2 test negative, Viral test, Visual impairment — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: 10-15 minute period of decreased vision, dizziness and nausea on 1/7/2021 evening. Intermittent nausea and moderate fatigue. Covid-19 swab done 1/8/2021 early morning was negative · Healthcare visit (other): Covid-19 test swab by employerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-26
- 2021-02-02
-
2021-02-09
Survey response — day 35, dose 2MedDRA: Depression, Fatigue, Headache, Musculoskeletal stiffness — Feeling: FairFree text: Headaches, neck stiffness, fatigue and depressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — day 42, dose 2MedDRA: Diarrhoea, Headache, Musculoskeletal stiffness, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Still having intermittent diarrhea, nausea, neck stiffness and headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-05-13
-
2021-07-10
Survey response — 6 months, dose 2MedDRA: Cough, Dysarthria, Gastroenteritis, Headache, Hypoglossal nerve disorder, Muscle contractions involuntary, Nausea, Physiotherapy, Tongue disorder, Upper respiratory tract infection, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Hypoglossal neuritis/neuralgia with intermittent tongue retraction and fasiculations, and intermittent slurred speech lasting approximately 4 weeks. Severe neck pain and headache Gastroenteritis with nausea/vomiting. Cough upper respiratory infection · Healthcare visit (other): MRI, carotid ultrasound , laryngeal scop, lab work, IV fluids, physical therapyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-10
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-15
-
2021-07-27
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-29
Dose 3 — Pfizer-BioNTech
-
2022-01-05
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid 19MedDRA releases: 2024-11 · check-in free text available
-
2022-01-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-06
-
2022-03-31
Dose 4 — Pfizer-BioNTech
- 2022-04-19
- 2022-04-21
- 2022-04-28
-
2022-05-05
Survey response — day 35, dose 4MedDRA: Body temperature increased, Chills, Diarrhoea, Fatigue, Nausea, Pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Low grade temperature, body aches, nausea, diarrhea, chills, fatigue for 2 1/2 days 4/30/22-5/2/22MedDRA releases: 2024-11 · check-in free text available
- 2022-05-13
- 2022-06-30
-
2022-09-30
Survey response — 6 months, dose 4MedDRA: Fear, Glossopharyngeal neuralgia, Office visit, Oromandibular dystonia, Protrusion tongue, Speech disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: I still have difficulty with my tongue and speech. My tongue protrudes to my left side when I attempt to protrude it straight out. · Healthcare visit (other): First symptoms 4/19/21. Saw neurologist 6/29/21. Diagnosed with glossal pharyngeal neuralgia with dystonia of tongue. Symptoms had mostly resolved, but since my 4th Covid vaccine, my tongue is worse again. I am afraid to get a 5th vaccine.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-03
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-03
Call successfulParticipant prefers to complete VAERS report online
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
| 4 | 2022-03-31 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
1 wait over 3 months for a first call
Free text
Release 1 — day 14, dose 1
Symptoms: Slight nausea and anorexia on 12/26/20 and some continuing anorexia since then. Maybe a bit more fatigue than normal, but may have been due to Christmas holiday activities
Release 2 — day 14, dose 2
Symptoms: 10-15 minute period of decreased vision, dizziness and nausea on 1/7/2021 evening. Intermittent nausea and moderate fatigue. Covid-19 swab done 1/8/2021 early morning was negative
Healthcare visit (other): Covid-19 test swab by employer
Release 3 — day 35, dose 2
Symptoms: Headaches, neck stiffness, fatigue and depression
Release 4 — day 42, dose 2
Symptoms: Still having intermittent diarrhea, nausea, neck stiffness and headache
Release 9 — 6 months, dose 2
Symptoms: Hypoglossal neuritis/neuralgia with intermittent tongue retraction and fasiculations, and intermittent slurred speech lasting approximately 4 weeks. Severe neck pain and headache Gastroenteritis with nausea/vomiting. Cough upper respiratory infection cut off by CDC
Healthcare visit (other): MRI, carotid ultrasound , laryngeal scop, lab work, IV fluids, physical therapy
Release 10 — 12 months, dose 2
Symptoms: Covid 19
Release 11 — day 35, dose 4
Symptoms: Low grade temperature, body aches, nausea, diarrhea, chills, fatigue for 2 1/2 days 4/30/22-5/2/22
Release 12 — 6 months, dose 4
Symptoms: I still have difficulty with my tongue and speech. My tongue protrudes to my left side when I attempt to protrude it straight out.
Healthcare visit (other): First symptoms 4/19/21. Saw neurologist 6/29/21. Diagnosed with glossal pharyngeal neuralgia with dystonia of tongue. Symptoms had mostly resolved, but since my 4th Covid vaccine, my tongue is worse again. I am afraid to get a 5th vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Fear | · | · | ✓ |
| HCVO | Glossopharyngeal neuralgia | · | · | ✓ |
| HCVO | Magnetic resonance imaging | ○ | ○ | ○ |
| HCVO | Office visit | ○ | ✓ | ✓ |
| HCVO | Oromandibular dystonia | · | · | ✓ |
| HCVO | Physiotherapy | ✓ | ✓ | ✓ |
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| HCVO | Viral test | ○ | ✓ | ○ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Culture negative | ○ | ✓ | ○ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Depression | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dysarthria | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastroenteritis | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoglossal nerve disorder | ✓ | ✓ | ✓ |
| SD | Muscle contractions involuntary | ✓ | ✓ | ✓ |
| SD | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ○ | ○ | ○ |
| SD | Pain | · | · | ✓ |
| SD | Protrusion tongue | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Speech disorder | · | · | ✓ |
| SD | Tongue disorder | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SD | Visual impairment | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release